Pierre Péterlin

Eprenetapopt Plus Azacitidine in <i>TP53</i>-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)

Thomas Cluzeau, Marie Sébert, Ramy Rahmé et al. · Journal of Clinical Oncology · 2021 · 268 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)

Laurence Millon, Raoul Herbrecht, Frédéric Grenouillet et al. · Clinical Microbiology and Infection · 2015 · 254 citations

Veterinary Medicine, Infectious Diseases, Microbiology +17

Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory <i>IDH1</i>-mutated AML

Stéphane de Botton, Pierre Fenaux, Karen Yee et al. · Blood Advances · 2023 · 124 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé et al. · Blood Advances · 2019 · 121 citations · Full text

Medicine, Hematology, Oncology +17

Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort

Edmond Chiche, Ramy Rahmé, Sarah Bertoli et al. · Blood Advances · 2021 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17